Showing 610 – 620 of 1303 results
-
Michael Pezzuto
View biography for Michael Pezzuto, senior wealth planner II.
-
Ken Langston
View biography for Ken Langston, Partner, Managing Director, Private Wealth Management Branch Leadership.
-
Second Quarter Earnings Preview
In this Economics Weekly, we break down the past quarter’s earnings and preview the main factors that we will be looking for from a macro perspective.
-
2025 Wealth Planning and Philanthropy Strategies
Last year’s election results have set the stage for significant changes in tax legislation. We explore several strategies you might consider to help you meet your financial, wealth-transfer, and philanthropic goals.
-
The Quarterly Rx Q1 2023 US Biopharma Recap
The year kicked off with renewed optimism for the biopharma sector, but “macro” concerns resurfaced to end the quarter.
-
The Quarterly Rx Q2 2023 US Biopharma Recap
Biopharma markets closed the first half of 2023 with renewed optimism and an encouraging outlook for the rest of the year.
-
Cybersecurity 2020 Trust No One Verify Everyone
The term zero trust has become the next in a long line of popular terms used by cybersecurity companies to associate their offerings with a more sophisticated, next-generation approach.
-
Ellen Blair Chube Receives Emerging Philanthropist Award
Ellen-Blair Chube, a William Blair partner and a managing director with the firm’s investment banking team, received the emerging philanthropist award from the Association of Fundraising Professionals (AFP) in Chicago at its annual gala.
-
iRhythm Technologies Inc Initiation
William Blair & Company initiated research coverage of iRhythm Technologies, Inc. (IRTC $71.50), a digital health company that provides solutions designed for diagnosing cardiac arrhythmias.
-
Thryv Holdings Inc Initiation
William Blair & Company initiated research coverage of Thryv Holdings, Inc. (THRY $10.04). Thryv helps small and local businesses get discovered by customers.